Literature DB >> 2999186

Comparison of six methods for the detection of antibody to cytomegalovirus.

T M McHugh, C H Casavant, J C Wilber, D P Stites.   

Abstract

Five commercial assays were compared to a standardized complement fixation (CF) test for the detection of antibody to cytomegalovirus. Two hundred and thirty serum specimens were analyzed. In addition, nine pairs of acute- and convalescent-phase sera were tested by two of the commercial assays. The assays were compared as to sensitivity, specificity, and positive and negative predictive value, as well as incidence of false-positive and -negative results. Samples which did not agree in all the assays were retested and tested with an indirect fluorescent-antibody assay. Of 228 specimens, 103 (45.2%) were positive by CF. Of the 230 samples, 2 (0.9%) were inconclusive by CF and readable in the other assays. Of the 230 specimens, 97 (42.2%) were positive by an enzyme immunoassay (EIA; Litton Bionetics), 100 (43.5%) were positive by a second EIA (Abbott Laboratories), 104 (45.2%) were positive by a third EIA (M. A. Bioproducts). One hundred and eight (47.0%) were positive by indirect hemagglutination (IHA; Cetus Corporation), and 110 (47.8%) were positive by latex agglutination (LA; Hynson, Westcott and Dunning). Sensitivity and specificity were similar with all the assays (93 to 100%). The greater numbers of positive results by IHA and LA were confirmed by repeat CF testing at less than 1:8 dilution, and by indirect fluorescent-antibody assay. Acute- and convalescent-phase serum pairs showed a significant rise in antibody titer when tested by anticomplement immunofluorescence, IHA, and LA. There was good agreement among the assays, with LA having the highest sensitivity.

Mesh:

Substances:

Year:  1985        PMID: 2999186      PMCID: PMC271869          DOI: 10.1128/jcm.22.6.1014-1019.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Infections with cytomegalovirus in bone marrow transplantation: report of a workshop.

Authors:  J S Pagano
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus.

Authors:  D G Beckwith; D C Halstead; K Alpaugh; A Schweder; D A Blount-Fronefield; K Toth
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

3.  Anticomplement immunofluorescence test that uses isolated fibroblast nuclei for detection of antibodies to human cytomegalovirus.

Authors:  L Mintz; R C Miner; A S Yeager
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

4.  Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays.

Authors:  J A Brandt; J D Kettering; J E Lewis
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

5.  Comparison of five methods of cytomegalovirus antibody screening of blood donors.

Authors:  P H Phipps; L Grégoire; E Rossier; E Perry
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

6.  Disease due to cytomegalovirus and its long-term consequences in renal transplant recipients. Correlation of allograft survival with disease due to cytomegalovirus and rubella antibody level.

Authors:  J P Luby; A J Ware; A R Hull; J H Helderman; P Gailiunas; S Butler; C Atkins
Journal:  Arch Intern Med       Date:  1983-06

7.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.

Authors:  A S Yeager; F C Grumet; E B Hafleigh; A M Arvin; J S Bradley; C G Prober
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

8.  Cytomegalovirus infection and immunity in renal allograft recipients: assessment of the competence of humoral immunity.

Authors:  M W Rytel; J Balay
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

9.  Blood as a potential vehicle for the cytomegaloviruses.

Authors:  G R Monif; G I Daicoff; L L Flory
Journal:  Am J Obstet Gynecol       Date:  1976-10-15       Impact factor: 8.661

10.  The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody.

Authors:  W L Bayer; G E Tegtmeier
Journal:  Yale J Biol Med       Date:  1976-03
View more
  9 in total

1.  Comparison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipients.

Authors:  H Miller; B McCulloch; M P Landini; E Rossier
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Comparison of four techniques for detection of antibodies to cytomegalovirus.

Authors:  Y J Kraat; R M Hendrix; M P Landini; C A Bruggeman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service.

Authors:  D S Leland; K A Barth; E B Cunningham; J Jansen; G J Tricot; M L French
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Microparticle enzyme immunoassay for determination of immunoglobulin G antibodies to human cytomegalovirus.

Authors:  G Duverlie; C Roussel; M Driencourt; J Orfila
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  Simultaneous detection of antibodies to cytomegalovirus and herpes simplex virus by using flow cytometry and a microsphere-based fluorescence immunoassay.

Authors:  T M McHugh; R C Miner; L H Logan; D P Stites
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.

Authors:  S W Chou; K M Scott
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

7.  Comparison of four methods for screening of cytomegalovirus antibodies in normal donors and immunocompromised patients.

Authors:  F de Ory; P León; C Domingo; A Garcia-Sáiz; L Pérez; J M Echevarría
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

8.  Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Authors:  J Krowka; D Stites; J Mills; H Hollander; T McHugh; M Busch; L Wilhelm; L Blackwood
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

9.  Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus.

Authors:  J Dolan; J D Briggs; G B Clements
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.